NDASA’s public comments on the proposed rescheduling of marijuana – Part 1
by NDASA | Jun 24, 2024 | Advocacy, Drug Legislation, Feature, For Drug Testing Industry Professionals, Member Benefits
The Honorable Merrick B....Search this site
Stay in touch
Give to NDASA
Invest in safe and drug-free communities and workplaces and support NDASA.
Latest News & Updates
- Oct 16, 2025From stadium tours to safer workplaces – what entertainers can teach us about program management
- Oct 16, 20254 Things every employer should know about oral fluid testing
- Oct 13, 2025NDASA submits comments on DOT proposal to add fentanyl to drug testing panel
- Oct 07, 2025NDASA Announces 2026 Conferene Keynote Speaker: Dr. Stephen Loyd
- Aug 19, 2025URGENT Take Action NOW on Rescheduling Marijuana
Topics We Track
- Advocacy (15)
- Business Development (7)
- Committee Reports (1)
- DOT (21)
- Drug & Alcohol Testing (60)
- Drug Legislation (17)
- Feature (128)
- FMCSA (7)
- For Drug Testing Industry Professionals (24)
- For Employers and Workplace Safety & Wellness Professionals (18)
- Industry News (31)
- Marijuana & CBD (24)
- Member Benefits (4)
- Membership (6)
- MROs (3)
- NDASA Conference (19)
- NDASA Guidance (4)
- NDASA News (4)
- Newsletter Only (9)
- Opioids (3)
- Oral Fluid Testing (2)
- Partners (1)
- Resources (36)
- Substance Use (5)
- Substance Use/Addiction (10)
- The Voice (7)
- Training (5)
- Uncategorized (30)
- Workplace Safety (17)
- From stadium tours to safer workplaces – what entertainers can teach us about program management
- 4 Things every employer should know about oral fluid testing
- NDASA submits comments on DOT proposal to add fentanyl to drug testing panel
- NDASA Announces 2026 Conferene Keynote Speaker: Dr. Stephen Loyd
- URGENT Take Action NOW on Rescheduling Marijuana